Vexxel
Vexxel44
About
Vexxel is a biotechnology startup focused on advancing cell-free protein synthesis. Their platform aims to enable rapid and efficient production and engineering of proteins, which can accelerate research and development in various fields, including therapeutics and diagnostics.
Frequently asked
What does Vexxel do?
Vexxel is a biotechnology startup focused on advancing cell-free protein synthesis. Their platform aims to enable rapid and efficient production and engineering of proteins, which can accelerate research and development in various fields, including therapeutics and diagnostics.
What is Vexxel's revenue?
StartupHub estimates Vexxel's annual revenue at $1.3M (range $714K to $3.0M, 65% confidence), based on comparable companies in the sector.
Where is Vexxel headquartered?
Vexxel is headquartered in Cambridge, United States.
When was Vexxel founded?
Vexxel was founded in 2023.
What industry does Vexxel operate in?
Vexxel operates in Biotech, MedTech, Drug Discovery, Protein Engineering, Cell-Free Synthesis, Synthetic Biology.
How many employees does Vexxel have?
Vexxel has approximately 6 people on record.
HEADCOUNT
6
DOMAIN RATING
16
Comments
No comments yet. Be the first to share your take.